Clinical Trial Update: PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing PankoMab-GEX as maintenance therapy to placebo in advanced ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Epithelial Cancer
• Peritoneal Cancer

Drugs mentioned

• PankoMab-GEX (PankoMab-GEX)

Snippet

Sponsor: Glycotope GmbH | Conditions: Ovarian Epithelial Cancer Recurrent, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED